Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaotong Aerosol (消痛气雾剂) is a proprietary Tibetan medicinal formulation developed by Tibet Cheezheng Tibetan Medicine. It is a topical aerosol preparation indicated for the treatment of pain, swelling, and restricted mobility associated with acute soft tissue injuries, sprains, contusions, and chronic musculoskeletal conditions such as osteoarthritis and rheumatoid arthritis. The formulation is based on traditional Tibetan medical principles and contains a synergistic blend of botanical extracts, including *Lamiophlomis rotata* (Duyiwei), *Oxytropis falcata* (Duxia), *Tinospora sinensis* (Kuanjinteng), and *Curcuma longa* (Jianghuang). These active constituents exert analgesic and anti-inflammatory effects by modulating inflammatory mediators like prostaglandins and cytokines, while also improving local microcirculation at the site of application. The aerosol delivery system facilitates rapid absorption and targeted relief for localized pain management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaotong Aerosol.